161 related articles for article (PubMed ID: 32046103)
1. The Effect of 3'-Hydroxy-3,4,5,4'-Tetramethoxy -stilbene, the Metabolite of the Resveratrol Analogue DMU-212, on the Motility and Proliferation of Ovarian Cancer Cells.
Nowicki A; Skupin-Mrugalska P; Jozkowiak M; Wierzchowski M; Rucinski M; Ramlau P; Krajka-Kuzniak V; Jodynis-Liebert J; Piotrowska-Kempisty H
Int J Mol Sci; 2020 Feb; 21(3):. PubMed ID: 32046103
[TBL] [Abstract][Full Text] [Related]
2. 3'-hydroxy-3,4,5,4'-tetramethoxystilbene, the metabolite of resveratrol analogue DMU-212, inhibits ovarian cancer cell growth in vitro and in a mice xenograft model.
Piotrowska-Kempisty H; Ruciński M; Borys S; Kucińska M; Kaczmarek M; Zawierucha P; Wierzchowski M; Łażewski D; Murias M; Jodynis-Liebert J
Sci Rep; 2016 Sep; 6():32627. PubMed ID: 27585955
[TBL] [Abstract][Full Text] [Related]
3. Role of CYP1A1 in the biological activity of methylated resveratrol analogue, 3,4,5,4'-tetramethoxystilbene (DMU-212) in ovarian cancer A-2780 and non-cancerous HOSE cells.
Piotrowska-Kempisty H; Klupczyńska A; Trzybulska D; Kulcenty K; Sulej-Suchomska AM; Kucińska M; Mikstacka R; Wierzchowski M; Murias M; Baer-Dubowska W; Kokot Z; Jodynis-Liebert J
Toxicol Lett; 2017 Feb; 267():59-66. PubMed ID: 28049037
[TBL] [Abstract][Full Text] [Related]
4. The Effect of 4'-hydroxy-3,4,5-trimetoxystilbene, the Metabolite of Resveratrol Analogue DMU-212, on Growth, Cell Cycle and Apoptosis in DLD-1 and LOVO Colon Cancer Cell Lines.
Jozkowiak M; Skupin-Mrugalska P; Nowicki A; Borys-Wojcik S; Wierzchowski M; Kaczmarek M; Ramlau P; Jodynis-Liebert J; Piotrowska-Kempisty H
Nutrients; 2020 May; 12(5):. PubMed ID: 32392733
[TBL] [Abstract][Full Text] [Related]
5. Resveratrol analogue 3,4,4',5-tetramethoxystilbene inhibits growth, arrests cell cycle and induces apoptosis in ovarian SKOV-3 and A-2780 cancer cells.
Piotrowska H; Myszkowski K; Ziółkowska A; Kulcenty K; Wierzchowski M; Kaczmarek M; Murias M; Kwiatkowska-Borowczyk E; Jodynis-Liebert J
Toxicol Appl Pharmacol; 2012 Aug; 263(1):53-60. PubMed ID: 22687606
[TBL] [Abstract][Full Text] [Related]
6. DMU-212 inhibits tumor growth in xenograft model of human ovarian cancer.
Piotrowska H; Myszkowski K; Abraszek J; Kwiatkowska-Borowczyk E; Amarowicz R; Murias M; Wierzchowski M; Jodynis-Liebert J
Biomed Pharmacother; 2014 May; 68(4):397-400. PubMed ID: 24768110
[TBL] [Abstract][Full Text] [Related]
7. Enhanced biological activity of liposomal methylated resveratrol analog 3'-hydroxy-3,4,5,4'-tetramethoxystilbene (DMU-214) in 3D patient-derived ovarian cancer model.
Nowicki A; Wawrzyniak D; Czajkowski M; Józkowiak M; Pawlak M; Wierzchowski M; Rolle K; Skupin-Mrugalska P; Piotrowska-Kempisty H
Drug Deliv; 2022 Dec; 29(1):2459-2468. PubMed ID: 35892260
[TBL] [Abstract][Full Text] [Related]
8. Individual and Combined Treatments with Methylated Resveratrol Analogue DMU-214 and Gefitinib Inhibit Tongue Cancer Cells Growth via Apoptosis Induction and EGFR Inhibition.
Jozkowiak M; Dyszkiewicz-Konwinska M; Ramlau P; Kranc W; Spaczynska J; Wierzchowski M; Kaczmarek M; Jodynis-Liebert J; Piotrowska-Kempisty H
Int J Mol Sci; 2021 Jun; 22(12):. PubMed ID: 34201116
[TBL] [Abstract][Full Text] [Related]
9. Resveratrol analog trans 3,4,5,4'-tetramethoxystilbene (DMU-212) mediates anti-tumor effects via mechanism different from that of resveratrol.
Ma Z; Molavi O; Haddadi A; Lai R; Gossage RA; Lavasanifar A
Cancer Chemother Pharmacol; 2008 Dec; 63(1):27-35. PubMed ID: 18286288
[TBL] [Abstract][Full Text] [Related]
10. Different susceptibility of colon cancer DLD-1 and LOVO cell lines to apoptosis induced by DMU-212, a synthetic resveratrol analogue.
Piotrowska H; Myszkowski K; Amarowicz R; Murias M; Kulcenty K; Wierzchowski M; Jodynis-Liebert J
Toxicol In Vitro; 2013 Dec; 27(8):2127-34. PubMed ID: 24055891
[TBL] [Abstract][Full Text] [Related]
11. Development and validation of HPLC-MS/MS procedure for determination of 3,4,4',5-tetra-methoxystilbene (DMU-212) and its metabolites in ovarian cancer cells and culture medium.
Klupczynska A; Sulej-Suchomska AM; Piotrowska-Kempisty H; Wierzchowski M; Jodynis-Liebert J; Kokot ZJ
J Chromatogr B Analyt Technol Biomed Life Sci; 2017 Aug; 1060():30-35. PubMed ID: 28582662
[TBL] [Abstract][Full Text] [Related]
12. Steroidogenic activity of liposomal methylated resveratrol analog 3,4,5,4'-tetramethoxystilbene (DMU-212) in human luteinized granulosa cells in a primary three-dimensional in vitro model.
Józkowiak M; Kobylarek D; Bryja A; Gogola-Mruk J; Czajkowski M; Skupin-Mrugalska P; Kempisty B; Spaczyński RZ; Piotrowska-Kempisty H
Endocrine; 2023 Dec; 82(3):681-694. PubMed ID: 37572199
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and Evaluation of 2-Naphthaleno trans-Stilbenes and Cyanostilbenes as Anticancer Agents.
Madadi NR; Penthala NR; Ketkar A; Eoff RL; Trujullo-Alonso V; Guzman ML; Crooks PA
Anticancer Agents Med Chem; 2018; 18(4):556-564. PubMed ID: 28403783
[TBL] [Abstract][Full Text] [Related]
14. Resveratrol inhibits IL-6-induced ovarian cancer cell migration through epigenetic up-regulation of autophagy.
Ferraresi A; Phadngam S; Morani F; Galetto A; Alabiso O; Chiorino G; Isidoro C
Mol Carcinog; 2017 Mar; 56(3):1164-1181. PubMed ID: 27787915
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetics in mice and growth-inhibitory properties of the putative cancer chemopreventive agent resveratrol and the synthetic analogue trans 3,4,5,4'-tetramethoxystilbene.
Sale S; Verschoyle RD; Boocock D; Jones DJ; Wilsher N; Ruparelia KC; Potter GA; Farmer PB; Steward WP; Gescher AJ
Br J Cancer; 2004 Feb; 90(3):736-44. PubMed ID: 14760392
[TBL] [Abstract][Full Text] [Related]
16. Effect of resveratrol analogue, DMU-212, on antioxidant status and apoptosis-related genes in rat model of hepatocarcinogenesis.
Piotrowska H; Kujawska M; Nowicki M; Petzke E; Ignatowicz E; Krajka-Kuźniak V; Zawierucha P; Wierzchowski M; Murias M; Jodynis-Liebert J
Hum Exp Toxicol; 2017 Feb; 36(2):160-175. PubMed ID: 27048571
[TBL] [Abstract][Full Text] [Related]
17. Resveratrol and acetyl-resveratrol modulate activity of VEGF and IL-8 in ovarian cancer cell aggregates via attenuation of the NF-κB protein.
Tino AB; Chitcholtan K; Sykes PH; Garrill A
J Ovarian Res; 2016 Dec; 9(1):84. PubMed ID: 27906095
[TBL] [Abstract][Full Text] [Related]
18. [Study on the effect of resveratrol on metastasis-associated ability of ovarian carcinoma HO-8910PM cells in vitro].
Qin YM; Li K; He TP; Mo LE; Liang NC
Zhong Yao Cai; 2007 Feb; 30(2):176-8. PubMed ID: 17571767
[TBL] [Abstract][Full Text] [Related]
19. Anticancer effects of novel resveratrol analogues on human ovarian cancer cells.
Vergara D; De Domenico S; Tinelli A; Stanca E; Del Mercato LL; Giudetti AM; Simeone P; Guazzelli N; Lessi M; Manzini C; Santino A; Bellina F; Maffia M
Mol Biosyst; 2017 May; 13(6):1131-1141. PubMed ID: 28429008
[TBL] [Abstract][Full Text] [Related]
20. Resveratrol exerts differential effects in vitro and in vivo against ovarian cancer cells.
Stakleff KS; Sloan T; Blanco D; Marcanthony S; Booth TD; Bishayee A
Asian Pac J Cancer Prev; 2012; 13(4):1333-40. PubMed ID: 22799328
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
